Market Overview:
The global medical perfusion system market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of chronic diseases, rising geriatric population, and technological advancements in medical perfusion systems. Based on type, the global medical perfusion system market is segmented into cardiopulmonary perfusion, cell perfusion, and ex vivo organ perfusion. Cardiopulmonary Perfusions are used for heart surgery or other surgeries that require stopping blood flow through the heart temporarily. Cell Perfusions are used for culturing cells outside of their natural environment and studying their behavior or testing new drugs on them.
Product Definition:
A medical perfusion system is a device that circulates blood or other fluids through the body in order to provide life-sustaining treatment. The importance of medical perfusion systems cannot be overstated, as they are essential for providing patients with critical care.
Cardiopulmonary Perfusion:
Cardiopulmonary perfusion (CPP) is a technique that uses cardiopulmonary bypass to provide blood flow and oxygenation outside of the body. CPP machines are used in cardiac surgery, heart transplant procedures, and for providing emergency treatment for patients suffering from severe bleeding or anemia.
Cell Perfusion:
Cell perfusion is a process of providing cell-based therapy to organs or tissues by delivering the required amount of blood flow. It helps in increasing the oxygen and nutrient supply to cells, which improves their function as well as survival rate. Cell perfusion system market is expected to witness lucrative growth over the forecast period owing to factors such as rising prevalence of chronic diseases, increasing demand for organ transplantation procedures along with growing R&D activities pertaining to novel product development.
Application Insights:
Based on application, the global market is segmented into hospitals, ambulatory surgical centers, and clinics. The hospitals segment dominated the overall market in terms of revenue in 2017 owing to an increase in patient admissions and a growing geriatric population across the globe. Moreover, an increase in cardiovascular diseases has resulted in a significant rise in hospital admissions for this condition which further drives demand for medical perfusion systems at a high rate.
The clinics segment is expected to grow at fastest rate during forecast period due to increasing awareness about organ donation coupled with rising disposable income among people globally. Increasing number of transplantation surgeries also contribute towards higher adoption of these systems among clinics as compared to other segments.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to factors such as increasing R&D investments by key players, rising adoption of new technologies, and high healthcare expenditure in the region. Moreover, growing number of FDA approvals for various products is also expected to drive growth during the forecast period. For instance, Cardiome Medical received approval from FDA for its Cell-Perfusion System that enables perfusion of cells using acellular solution instead of whole blood which reduces transfusion requirements and increases safety during surgery or cardiac procedures.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure due to government initiatives.
Growth Factors:
- Increasing incidence of cardiovascular diseases: The increasing incidence of cardiovascular diseases is one of the key growth drivers for the medical perfusion system market. According to a study by the World Health Organization (WHO), an estimated 17.5 million people died from cardiovascular diseases in 2012, accounting for 31% of all global deaths. This number is expected to increase to 23 million by 2030. This growing prevalence of cardiovascular diseases is thus expected to drive demand for medical perfusion systems in the coming years.
- Rising geriatric population: The global geriatric population is growing at a rapid pace and this is expected to be a major driver for the medical perfusion system market in the coming years. As per estimates by United Nations, there were around 809 million people aged 60 or above in 2015 and this number is projected to reach 2 billion by 2050. This rising geriatric population will create greater demand for advanced medical technologies such as medical perfusion systems, which are used specifically for treating elderly patients with various health conditions..
Scope Of The Report
Report Attributes
Report Details
Report Title
Medical Perfusion System Market Research Report
By Type
Cardiopulmonary Perfusion, Cell Perfusion, Ex Vivo Organ Perfusion
By Application
Hospitals, Ambulatory Surgical Centers, Clinics
By Companies
GE Healthcare, Philips Healthcare, Toshiba Medical Systems, Hitachi Healthcare, Samsung Medison, Medtronic, Shimadzu Corporation, Siemens Healthineers, Accuray Incorporated, Organ Assist B.V, GE Healthcare, Organ Recovery Systems, Paragonix Technologies, Inc, Waters Medical Systems, TransMedics, Inc, Bridge to Life Ltd, OrganOx Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
192
Number of Tables & Figures
135
Customization Available
Yes, the report can be customized as per your need.
Global Medical Perfusion System Market Report Segments:
The global Medical Perfusion System market is segmented on the basis of:
Types
Cardiopulmonary Perfusion, Cell Perfusion, Ex Vivo Organ Perfusion
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centers, Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GE Healthcare
- Philips Healthcare
- Toshiba Medical Systems
- Hitachi Healthcare
- Samsung Medison
- Medtronic
- Shimadzu Corporation
- Siemens Healthineers
- Accuray Incorporated
- Organ Assist B.V
- GE Healthcare
- Organ Recovery Systems
- Paragonix Technologies, Inc
- Waters Medical Systems
- TransMedics, Inc
- Bridge to Life Ltd
- OrganOx Ltd
Highlights of The Medical Perfusion System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cardiopulmonary Perfusion
- Cell Perfusion
- Ex Vivo Organ Perfusion
- By Application:
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Medical Perfusion System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A medical perfusion system is a machine that helps deliver blood and other vital fluids to patients in need. It can be used to provide life-saving treatments, such as during surgery or childbirth.
Some of the major companies in the medical perfusion system market are GE Healthcare, Philips Healthcare, Toshiba Medical Systems, Hitachi Healthcare, Samsung Medison, Medtronic, Shimadzu Corporation, Siemens Healthineers, Accuray Incorporated, Organ Assist B.V, GE Healthcare, Organ Recovery Systems, Paragonix Technologies, Inc, Waters Medical Systems, TransMedics, Inc, Bridge to Life Ltd, OrganOx Ltd.
The medical perfusion system market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Medical Perfusion System Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Medical Perfusion System Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Medical Perfusion System Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Medical Perfusion System Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Medical Perfusion System Market Size & Forecast, 2018-2028
4.5.1 Medical Perfusion System Market Size and Y-o-Y Growth
4.5.2 Medical Perfusion System Market Absolute $ Opportunity
Chapter 5 Global Medical Perfusion System Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Medical Perfusion System Market Size Forecast by Type
5.2.1 Cardiopulmonary Perfusion
5.2.2 Cell Perfusion
5.2.3 Ex Vivo Organ Perfusion
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Medical Perfusion System Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Medical Perfusion System Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Centers
6.2.3 Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Medical Perfusion System Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Medical Perfusion System Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Medical Perfusion System Analysis and Forecast
9.1 Introduction
9.2 North America Medical Perfusion System Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Medical Perfusion System Market Size Forecast by Type
9.6.1 Cardiopulmonary Perfusion
9.6.2 Cell Perfusion
9.6.3 Ex Vivo Organ Perfusion
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Medical Perfusion System Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Centers
9.10.3 Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Medical Perfusion System Analysis and Forecast
10.1 Introduction
10.2 Europe Medical Perfusion System Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Medical Perfusion System Market Size Forecast by Type
10.6.1 Cardiopulmonary Perfusion
10.6.2 Cell Perfusion
10.6.3 Ex Vivo Organ Perfusion
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Medical Perfusion System Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Centers
10.10.3 Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Medical Perfusion System Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Medical Perfusion System Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Medical Perfusion System Market Size Forecast by Type
11.6.1 Cardiopulmonary Perfusion
11.6.2 Cell Perfusion
11.6.3 Ex Vivo Organ Perfusion
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Medical Perfusion System Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Centers
11.10.3 Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Medical Perfusion System Analysis and Forecast
12.1 Introduction
12.2 Latin America Medical Perfusion System Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Medical Perfusion System Market Size Forecast by Type
12.6.1 Cardiopulmonary Perfusion
12.6.2 Cell Perfusion
12.6.3 Ex Vivo Organ Perfusion
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Medical Perfusion System Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Centers
12.10.3 Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Medical Perfusion System Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Medical Perfusion System Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Medical Perfusion System Market Size Forecast by Type
13.6.1 Cardiopulmonary Perfusion
13.6.2 Cell Perfusion
13.6.3 Ex Vivo Organ Perfusion
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Medical Perfusion System Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Centers
13.10.3 Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Medical Perfusion System Market: Competitive Dashboard
14.2 Global Medical Perfusion System Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GE Healthcare
14.3.2 Philips Healthcare
14.3.3 Toshiba Medical Systems
14.3.4 Hitachi Healthcare
14.3.5 Samsung Medison
14.3.6 Medtronic
14.3.7 Shimadzu Corporation
14.3.8 Siemens Healthineers
14.3.9 Accuray Incorporated
14.3.10 Organ Assist B.V
14.3.11 GE Healthcare
14.3.12 Organ Recovery Systems
14.3.13 Paragonix Technologies, Inc
14.3.14 Waters Medical Systems
14.3.15 TransMedics, Inc
14.3.16 Bridge to Life Ltd
14.3.17 OrganOx Ltd
